XLV News Alert Healthcare Select Sector SPDR (XLV) 68.67 11/18/2014

New Post Public Reply Private Reply Replies (0) Message Board

Nov 18, 2014 at 11:08 PM

Healthcare Select Sector SPDR (XLV) 68.67 $XLV

Dumb Investment Of The Week: Concentrated Mutual Funds And ETFs
Ben Strubel - Seeking Alpha - Tue Nov 18, 7:37AM CST
This week's Dumb Investment of the Week is inspired by Ken Heebner of CGM Focus's (MUTF: CGMFX ) colossally bad bet on interest rates rising. Unfortunately, he isn't the only fund manager to make concentrated bets that have been detrimental to...
EWW: 65.71 (-0.18), VOX: 89.99 (-0.11), XLV: 68.67 (+1.09)

Dow 30 Stock Roundup: Walmart, Cisco Post In-Line Results, Boeing Gets $8.5B Order - Analyst Blog
Swarup Gupta - Zacks Investment Research - Fri Nov 14, 1:29PM CST
The Dow had a largely positive week, but for Wednesday when it declined marginally.
T: 35.72 (-0.13), JPM: 60.53 (+0.15), XOM: 94.87 (-0.24), DIS: 90.28 (-0.13), WMT: 83.79 (+0.22), MSFT: 48.74 (-0.72), BA: 130.66 (+2.24), CVX: 115.47 (-0.28), CSCO: 26.59 (+0.12), XLV: 68.67 (+1.09), TV: 36.11 (+0.21)

Healthcare Stocks Hit on Obamacare Challenge - Analyst Blog
Swarup Gupta - Zacks Investment Research - Mon Nov 10, 10:32AM CST
The Supreme Court has agreed to hear a case challenging the subsidies made available by the Affordable Care Act (ACA).
HCA: 67.23 (+1.50), THC: 49.15 (+1.69), CYH: 48.82 (+2.32), UNH: 98.19 (+1.72), AET: 87.16 (+0.94), WLP: 129.04 (+1.77), XLV: 68.67 (+1.09)

Healthy Returns From The Healthcare Sector
Sy Harding - at Seeking Alpha - Mon Nov 10, 8:09AM CST
Healthcare stocks, along with the stocks of food and drink companies are often recommended as defensive holdings for bear markets, on the premise that no matter what happens people will always have to eat, drink, and take their medicine. The other...
RYH: 140.85 (+2.07), IYH: 144.25 (+2.40), RXL: 123.27 (+4.16), FHLC: 32.71 (+0.51), RXD: 15.47 (-0.47), CURE: 125.82 (+5.87), FXH: 59.40 (+0.98), VHT: 125.83 (+2.01), XLV: 68.67 (+1.09)

Diving Into Johnson & Johnson's Fundamentals
Valuentum - at Seeking Alpha - Mon Nov 10, 3:20AM CST

JNJ: 108.83 (+0.53), KMB: 113.60 (-0.05), PG: 87.95 (+0.11), XLV: 68.67 (+1.09)

The Best Offense Is A Good Defense
Eric Parnell, CFA - Seeking Alpha - Sat Nov 08, 8:36AM CST
What a difference a few weeks make. Stocks are once again in rally mode and bullishness is back on the street. After bottoming back on October 15, stocks as measured by the S&P 500 Index have rallied an impressive +11.6% to advance to fresh new...
XLB: 49.87 (+0.59), BDX: 130.94 (+1.40), SPLV: 37.14 (+0.15), DAL: 44.79 (+1.36), XLY: 69.33 (+0.13), BBY: 34.90 (-0.39), XLU: 45.66 (+0.13), SO: 47.25 (+0.17), XLV: 68.67 (+1.09), YHOO: 51.75 (-0.62), XLP: 48.26 (+0.18), SPY: 205.55 (+1.18), SPHB: 34.46 (+0.36), XLK: 41.67 (+0.14), PG: 87.95 (+0.11), XLI: 56.65 (+0.42), XLE: 85.83 (+0.07)

Global X Launches Sector Rotator ETF - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Nov 07, 7:01AM CST
This new fund from Global X looks to cycle between U.S. sectors to provide outperformance.
HUSE: 38.97 (+0.22), RWR: 88.55 (+0.42), SHY: 84.67 (-0.01), SCTO: 25.90 (+0.23), XLU: 45.66 (+0.13), XLV: 68.67 (+1.09)

Pause For A Cause: A 3-Month Outlook On The S&P 500 And U.S. 10-Year Yield
Cerebro1 - at Seeking Alpha - Wed Nov 05, 2:44PM CST

SPY: 205.55 (+1.18), IEF: 105.10 (+0.12), XLY: 69.33 (+0.13), XLK: 41.67 (+0.14), XLI: 56.65 (+0.42), XLU: 45.66 (+0.13), XLF: 24.14 (+0.08), XLV: 68.67 (+1.09)

A Valuation Snapshot By Sectors
Fred Piard - at Seeking Alpha - Wed Nov 05, 9:09AM CST

XLB: 49.87 (+0.59), XLP: 48.26 (+0.18), XLY: 69.33 (+0.13), XLK: 41.67 (+0.14), XLI: 56.65 (+0.42), XLU: 45.66 (+0.13), XLF: 24.14 (+0.08), XLV: 68.67 (+1.09), XLE: 85.83 (+0.07)

Japan Stimulus: Not My Cup Of Sake
Eric Parnell, CFA - Seeking Alpha - Sat Nov 01, 12:48PM CDT
Friday highlighted once again the importance of maintaining a long bias to stocks at least for now in an investment portfolio regardless of your long-term outlook for the global economy and its markets. In a surprise revelation, the Bank of Japan...
HYG: 91.26 (-0.18), ACWI: 60.06 (+0.44), FXY: 83.26 (-0.35), XLU: 45.66 (+0.13), UUP: 23.26 (-0.11), XLV: 68.67 (+1.09), EWJ: 11.74 (+0.16), SPY: 205.55 (+1.18), GLD: 115.05 (+1.00), OIL: 18.09 (-0.33), SPHB: 34.46 (+0.36), PFF: 39.93 (+0.01), EMB: 113.14 (+0.22), FXE: 123.47 (+0.84), SLV: 15.55 (+0.05), JJC: 36.15 (-0.52), JJA: 42.41 (-0.27)

Are XLV And The Health Care Sector Overpriced?
Fred Piard - at Seeking Alpha - Mon Oct 27, 5:09PM CDT

JNJ: 108.83 (+0.53), BIIB: 305.56 (+3.14), GILD: 103.71 (+3.27), UNH: 98.19 (+1.72), PFE: 30.59 (+0.27), MRK: 59.89 (+0.43), AMGN: 162.24 (+3.10), ABBV: 66.05 (+1.01), BMY: 58.70 (+0.27), XLV: 68.67 (+1.09), CELG: 106.78 (+2.42)

Weekly ETF Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Oct 24, 3:14PM CDT

IYH: 144.25 (+2.40), GDXJ: 29.36 (+1.86), QQQ: 103.68 (+0.77), VXX: 28.10 (-0.50), XHB: 32.25 (+0.08), GAZ: 2.65 (+0.01), BRF: 23.53 (+0.31), TAN: 36.33 (+1.72), EWZ: 39.76 (+0.86), XLV: 68.67 (+1.09)

Asset Class Performance Since The October 15th Short-Term Low
Bespoke Investment Group - Seeking Alpha - Thu Oct 23, 12:03AM CDT
Below is a look at how various asset classes (using tradeable ETFs) have performed since stocks put in a short-term bottom on October 15th. For each ETF, we also include its performance so far this month and year. As shown, US equities have surged...
INP: 74.38 (+0.48), XLB: 49.87 (+0.59), QQQ: 103.68 (+0.77), IJH: 143.59 (+0.85), RSX: 20.78 (+0.20), TLT: 119.52 (+0.33), XLV: 68.67 (+1.09), XLE: 85.83 (+0.07)

Consumer Discretionary ETF: No. 9 Select Sector SPDR Over 2014's First 9 Months
J.J. McGrath - at Seeking Alpha - Sat Oct 18, 11:12PM CDT

XLP: 48.26 (+0.18), SPY: 205.55 (+1.18), XLY: 69.33 (+0.13), XLU: 45.66 (+0.13), XLV: 68.67 (+1.09)

Energy ETF: No. 7 Select Sector SPDR Over 2014's First 9 Months
J.J. McGrath - at Seeking Alpha - Thu Oct 16, 6:20PM CDT

XLP: 48.26 (+0.18), SPY: 205.55 (+1.18), XLU: 45.66 (+0.13), XLE: 85.83 (+0.07), XLV: 68.67 (+1.09)

Consumer Staples ETF: No. 6 Select Sector SPDR Over 2014's First 9 Months
J.J. McGrath - at Seeking Alpha - Thu Oct 16, 1:11PM CDT

XLP: 48.26 (+0.18), SPY: 205.55 (+1.18), XLU: 45.66 (+0.13), XLV: 68.67 (+1.09)

Healthcare ETFs in Focus on JNJ Earnings Beat - ETF News And Commentary
Sweta Killa - ZACKS - Wed Oct 15, 12:00PM CDT
Investors should take a close look to healthcare ETFs following Johnson & Johnson earnings beat.
JNJ: 108.83 (+0.53), PPH: 65.57 (+1.06), IYH: 144.25 (+2.40), GILD: 103.71 (+3.27), ABBV: 66.05 (+1.01), XLV: 68.67 (+1.09)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Ping An's Bold Green Moves Ahead of APEC 2026

By Owen Jenkins Updated Oct 25, 2026 Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Love Business Group Helps SMEs Navigate Broadband Choices

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...